Welcome to Bristol Myers Squibb California

Bristol Myers Squibb’s robust and growing presence in California is transforming the way cancer and other difficult-to-treat diseases are approached. 

Scientists and researchers with diverse backgrounds and expertise in Brisbane, Redwood City, San Diego and San Francisco collaborate across teams, functions and sites to follow their own scientific curiosity, enabling fast, flexible science that ultimately increases the efficiency and success of drugs in the clinic. These efforts, at a time when the pace of technological advancements and creation of new biomedical knowledge is accelerating, are laying the foundation for investigational molecules that may one day have a significant therapeutic impact.

Meet our team

Learn about our leaders who are making a difference in California.

Join us as we transform patient lives through science 

Every day, each of us work to improve outcomes of patients fighting serious diseases. Together we’re building a better future for each other and the patients who need us the most. 

Driving innovation forward in California

Learn about our broad scope of scientific innovation in California.

Confronting the complexities of cancer >

Bristol Myers Squibb is driven to understand human biology and the complexities of cancer in order to advance the next generation of cancer therapies.

Looking to the future of cell therapy >

Bristol Myers Squibb is pursuing a multitude of diverse approaches in cell therapy to attack disease from new perspectives. 

Protein homeostasis 101: a Q&A with Mark Rolfe >

Hear from Mark Rolfe, Ph.D., as he describes protein homeostasis and protein degradation, and how the company is leveraging this novel research to make a difference for patients.

Building on today’s science to research medicines of tomorrow >

As a scientific research community, our work is never done for cancer patients. Building upon established science allows researchers to pursue new approaches, test new hypotheses and – ultimately – uncover new answers to emerging and enduring questions that may address unmet needs for patients. 

Improving Patients’ Lives Through Cell Therapy Research and Development – Kristen Hege >

Blood disease and cancer specialist Kristen Hege, who has been board-certified in hematology, medical oncology and internal medicine, joined BMS through the 2019 Celgene acquisition as the senior vice president of Early Clinical Development, Hematology/Oncology & Cell Therapy. She brings decades of CAR T cell therapy expertise to the company.

Community impact

Learn about how we are making a difference in communities across California

People and business resource groups >

People and Business Resource Groups (PBRGs) represent one key strategy we use to support the business objectives, career advancement and development needs of our employees.

California regional fact sheet >

Learn more about our impact in California.

Improving science education >

Science and technology are at the core of everything we do. We're always eager to open young minds to the exciting possibilities of both. 

Enhancing Cultural Intelligence to Deliver Healthcare Solutions >

Bristol Myers Squibb has partnered with PAN, which has helped employees connect with BMS customers & patients by enhancing cultural intelligence to get better healthcare solutions.

Additional resources

Learn more about our scientific approaches and innovation.

Protein degradation resources >

Learn about the science behind protein degradation and ongoing research that harnesses the power of this natural process.

Tumor microenvironment resources >

Exploring the tumor microenvironment (TME) to better understand how cancer and the immune system coexist is a core component of Bristol Myers Squibb’s research and early development strategy.

Cell therapy resources >

Novel cell-based therapies that use a person’s own cells are unlocking new potential in the fight against some of the most difficult-to-treat cancers.